Avid Bioservices to Present a Case Study on cGMP Production Scale-Up, Optimization and Transition From a Stainless Steel to a

Avid Bioservices to Present a Case Study on cGMP Production Scale-Up, 
Optimization and Transition From a Stainless Steel to a Fully
Disposable Process at BIO International Convention 
Study to Be Presented as Part of the BioProcess Theater Program
Follows a Biologics Production Process From an Early-Stage, Low-Yield
Stainless Steel Clinical Process to a High-Yield, Fully-Disposable
Commercializable Process Including Regulatory and Characterization
Strategies; Biomanufacturing Experts Will Be on Hand at Booth #4280 
TUSTIN, CA -- (Marketwired) -- 04/19/13 --  Avid Bioservices, Inc., a
subsidiary of Peregrine Pharmaceuticals, Inc., today announced its
upcoming participation at the Biotechnology Industry Organization's
(BIO) International Convention to be held at McCormick Place, in
Chicago, Illinois, April 22 - 25, 2013. At this global biotechnology
event, Avid will highlight a case study following an early-stage cGMP
production process in stainless steel bioreactors at 300 liter scale,
through a mid-stage clinical production process scale-up, toward a
commercializable fully-disposable production process. The case study
follows the strategies employed during the process evolution,
including regulatory and product comparability testing and results.
Avid is focused on continuously improving manufacturing flexibility
and efficiency utilizing both stainless steel and single-use
technologies, in order to reduce operation costs and accelerate speed
to market. Avid is one of the first CMOs to implement disposable
systems into its biomanufacturing production strategies. This case
study highlights the integrated solutions package offered by Avid to
maximize its clients' development and manufacturing programs. 
"The BIO conference is a great forum to share our advances in
achieving the best manufacturing practices for our clients as they
move through clinical development," said Gene Yoshioka, Director of
Manufacturing at Avid Bioservices. "Through our participation in the
BioProcess Theater program, attendees will learn firsthand the latest
developments arising from a recent comparability study on single-use
versus traditional stainless steel systems and how our applications
of single-use technologies yielded a more efficient upstream process.
This is just one example of how Avid is cons
istently striving to
improve the efficiency and flexibility of our manufacturing services
portfolio."  
Avid is scheduled to present at the BioProcess Theater within the
BioProcess Zone on the exhibit show floor: 
Date: 
 Tuesday, April 23, 2013  
Time: 
 11:00am - 11:25am CDT  
Title: 
 "Process Evolution from the Iron Age to the New Age: A
Transition from a Stainless Steel and Glass to a Fully Disposable
Upstream Process"  
Speakers: 
 Michael Brown, Senior Research Associate, Avid
Bioservices, Inc. 
 Connie Chang, Director, Process Science, Avid
Bioservices, Inc. 
In addition, as part of the biopartnering community, Avid Bioservices
(Booth #4280) will be conducting one-on-one partnering meetings with
industry colleagues.  
For additional information on the BIO International Convention,
please visit: http://convention.bio.org/ 
About Avid Bioservices
 Avid Bioservices provides a comprehensive
range of high quality cGMP manufacturing services for the
biotechnology and biopharmaceutical industries to support the
manufacture of cGMP clinical phase and commercial products. With over
15 years of experience producing monoclonal antibodies and
recombinant proteins in batch, fed-batch and perfusion modes, Avid's
services include GMP clinical and commercial product manufacturing,
purification, bulk packaging, final product filling, stability
testing and regulatory strategy, submission and support. The company
also provides a variety of process development activities, including
cell line optimization, cell culture and feed optimization,
analytical methods development and product characterization. For more
information about Avid, please visit www.avidbio.com. 
About Peregrine Pharmaceuticals
 Peregrine Pharmaceuticals, Inc. is a
biopharmaceutical company with a portfolio of innovative monoclonal
antibodies in clinical trials for the treatment of cancer and serious
viral infections. The company is pursuing multiple clinical programs
in cancer and infectious diseases with its lead product candidate
bavituximab and novel brain cancer agent Cotara(R). Peregrine also
has in-house cGMP manufacturing capabilities through its wholly-owned
subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides
development and biomanufacturing services for both Peregrine and
outside customers. Additional information about Peregrine can be
found at www.peregrineinc.com.   
Contact:
Chris Keenan or Kelly Pisarev Lord
(800) 987-8256
www.avidbio.com 
 
 
Press spacebar to pause and continue. Press esc to stop.